Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Blood|June 25, 2009
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allelePaola Guglielmelli, Giovanni Barosi, Giorgina Specchia, et al.
The New Microbiologica|July 18, 2024
Hepatitis C Virus (HCV) genotypes distribution in South-Eastern Tuscany: a ten-year retrospective studyAgostino Ognibene, Giulio Camarlinghi, Maria Lorubbio, et al.
Drug Design, Development and Therapy|June 2, 2015
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating studyNicola Cascavilla, Valerio De Stefano, Fabrizio Pane, et al.
Blood Advances|January 4, 2018
Targeted deep sequencing in polycythemia vera and essential thrombocythemiaAyalew Tefferi, Terra L Lasho, Paola Guglielmelli, et al.
Blood|March 30, 2017
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosisPaola Guglielmelli, Annalisa Pacilli, Giada Rotunno, et al.
Blood|April 12, 2013
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasmsElisa Rumi, Daniela Pietra, Paola Guglielmelli, et al.
Clinical Biochemistry|July 24, 2020
Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivityAlessandro Pancrazzi, Pasqualino Magliocca, Maria Lorubbio, et al.
American Journal of Hematology|June 7, 2016
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patientsPaola Guglielmelli, Giada Rotunno, Annalisa Pacilli, et al.
Blood|June 4, 2008
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemiaAlessandro M Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, et al.
Blood|November 7, 2012
Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutationVittorio Rosti, Laura Villani, Roberta Riboni, et al.
Pageof 4